Compagnie Lombard Odier SCmA’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$236K Hold
450
﹤0.01% 229
2025
Q1
$285K Hold
450
﹤0.01% 230
2024
Q4
$321K Hold
450
﹤0.01% 207
2024
Q3
$473K Hold
450
0.01% 184
2024
Q2
$473K Sell
450
-195
-30% -$205K 0.01% 184
2024
Q1
$621K Sell
645
-45
-7% -$43.3K 0.01% 181
2023
Q4
$606K Hold
690
0.01% 202
2023
Q3
$568K Sell
690
-1,090
-61% -$897K 0.01% 178
2023
Q2
$1.28M Hold
1,780
0.04% 131
2023
Q1
$1.46M Sell
1,780
-100
-5% -$82.2K 0.04% 142
2022
Q4
$1.36M Hold
1,880
0.04% 142
2022
Q3
$1.29M Hold
1,880
0.04% 148
2022
Q2
$1.11M Hold
1,880
0.03% 149
2022
Q1
$1.31M Hold
1,880
0.03% 141
2021
Q4
$1.19M Hold
1,880
0.02% 165
2021
Q3
$1.14M Buy
1,880
+810
+76% +$490K 0.02% 168
2021
Q2
$598K Sell
1,070
-105
-9% -$58.7K 0.01% 207
2021
Q1
$556K Sell
1,175
-175
-13% -$82.8K 0.01% 261
2020
Q4
$652K Buy
1,350
+80
+6% +$38.6K 0.02% 197
2020
Q3
$711K Buy
1,270
+280
+28% +$157K 0.02% 168
2020
Q2
$617K Sell
990
-190
-16% -$118K 0.02% 173
2020
Q1
$576K Buy
1,180
+380
+48% +$185K 0.02% 167
2019
Q4
$300K Sell
800
-101
-11% -$37.9K 0.01% 221
2019
Q3
$250K Hold
901
0.01% 229
2019
Q2
$282K Sell
901
-277
-24% -$86.7K 0.01% 219
2019
Q1
$483K Sell
1,178
-300
-20% -$123K 0.02% 199
2018
Q4
$552K Buy
1,478
+78
+6% +$29.1K 0.02% 190
2018
Q3
$566K Hold
1,400
0.02% 194
2018
Q2
$483K Sell
1,400
-60
-4% -$20.7K 0.02% 209
2018
Q1
$503K Sell
1,460
-1,526
-51% -$526K 0.02% 220
2017
Q4
$1.12M Buy
+2,986
New +$1.12M 0.02% 221
2017
Q2
Sell
-70
Closed -$27K 734
2017
Q1
$27K Buy
+70
New +$27K ﹤0.01% 596
2015
Q2
Sell
-216
Closed -$98K 912
2015
Q1
$98K Hold
216
﹤0.01% 663
2014
Q4
$89K Sell
216
-487
-69% -$201K ﹤0.01% 560
2014
Q3
$254K Sell
703
-229
-25% -$82.7K 0.01% 450
2014
Q2
$263K Hold
932
0.01% 468
2014
Q1
$280K Buy
932
+393
+73% +$118K 0.01% 440
2013
Q4
$148K Buy
+539
New +$148K 0.01% 587